Cargando…

TNF-alfa blockers- promising therapy for chronic uveitis in very young children

Detalles Bibliográficos
Autores principales:	Tauber, T, Dolinski, G, Morad, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333941/ http://dx.doi.org/10.1186/1546-0096-6-S1-P143

Ejemplares similares

Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011)

Response of pediatric uveitis to TNFα inhibitors
por: Lerman, Melissa A, et al.
Publicado: (2012)

TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Efficacy of TNF blockers from the perspective of growth velocity: slovak experience
por: Mrážik, Pavol, et al.
Publicado: (2014)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Non-anti TNF biologic modifier drugs in non-infectious refractory chronic uveitis: the current evidence from a systematic review
por: Simonini, Gabriele, et al.
Publicado: (2014)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

FMF in heterozygotes: are we able to accurately diagnose the disease in very young children?
por: Hentgen, Véronique, et al.
Publicado: (2011)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Epidemiology of uveitis in children over a 10 years period
por: Clarke, Lydia, et al.
Publicado: (2011)

PReS-FINAL-2347: Does switching anti-TNFΑ biologic agents an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach
por: Simonini, G, et al.
Publicado: (2013)

Increasing microcirculation after drotrecogin alfa (activated)
por: Donati, A, et al.
Publicado: (2007)

Retrospective observational outcomes for drotrecogin alfa (activated)
por: Cameron, C, et al.
Publicado: (2007)

Interleukine-6 and TNFα blockers provide only partial and short-term temporal improvement in cryopyrin-associated periodic syndrome
por: Dolgikh, Vladimir, et al.
Publicado: (2014)

Use of national guidelines for the introduction of Drotrecogin alfa (activated)
por: Mackenzie, S, et al.
Publicado: (2004)

First results of the uveitis outcome study of the multinational interdisciplinary working group for uveitis in childhood (MIWGUC)
por: Foeldvari, Ivan, et al.
Publicado: (2014)

Extended drotrecogin alfa (activated) therapy in patients with persistent requirement for vasopressor support after 96-hour infusion with commercial drotrecogin alfa (activated)
por: Dhainaut, J, et al.
Publicado: (2008)

A first description of chronic arthritis and uveitis in an adolescent girl with glycogen storage disease
por: Watanabe Duffy, Karen N, et al.
Publicado: (2012)

PReS-FINAL-2266: A rare cause for childhood uveitis: TINU (tubulointerstitial nephritis and uveitis) syndrome
por: Barut, K, et al.
Publicado: (2013)

PReS-FINAL-2153: Intestinal gamma/delta- T cells are upregulated in children with active uveitis
por: Arvonen, M, et al.
Publicado: (2013)

PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis
por: Walscheid, K, et al.
Publicado: (2013)

Drotrecogin alfa: start early, ensure response, stop early!
por: Jog, S, et al.
Publicado: (2008)

A comparison of two types of new bronchial blockers, Uniblocker™ and Coopdech endotracheal blocker tube, for one-lung ventilation during thoracoscopy
por: Iizuka, T, et al.
Publicado: (2007)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic
por: Simonini, G, et al.
Publicado: (2011)

Current evidence of MTX efficacy in childhood chronic uveitis: a systematic review and meta-analysis
por: Simonini, G, et al.
Publicado: (2011)

First episode of chronic anterior uveitis in patients with juvenile idiopathic arthritis and relationship with administrated treatments
por: Boteanu, Alina Lucica, et al.
Publicado: (2014)

Drotrecogin alfa (activated): a single-centre experience of 110 patients
por: Fletcher, S, et al.
Publicado: (2010)

Drotrecogin alfa (activated) does not impair platelet receptor expression in vitro
por: Schuerholz, T, et al.
Publicado: (2004)

Multicentre audit of the use of drotrecogin alfa (activated) in UK critical care units
por: Rowan, K, et al.
Publicado: (2007)

A large, single-centre UK registry of drotrecogin alfa-activated use
por: Macchiavello, L, et al.
Publicado: (2007)

Severe sepsis and drotrecogin alfa (activated) use: results from the PROGRESS registry
por: Beale, R, et al.
Publicado: (2007)

Eligibility for drotrecogin alfa therapy on the basis of APACHE II score and organ failure
por: Shulman, R, et al.
Publicado: (2005)

Effect of β-blockers and calcium channel blockers on shock index predictability in patients suffering from urosepsis
por: Cliche, J, et al.
Publicado: (2013)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

PReS-FINAL-2327: Abatacept in the treatment of refractory uveitis
por: Moretti, D, et al.
Publicado: (2013)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Audit of adherence to National Institute of Clinical Excellence guidelines for the use of drotrecogin alfa (activated)
por: Vedantham, R, et al.
Publicado: (2007)

Neuroaxial catheters following abdominal surgery and their impact on the use of Drotrecogin alfa (activated) in sepsis
por: Steel, A, et al.
Publicado: (2004)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_m77jdl5prdv2c8otbqjprbpah6